Brokerages bullish on L&T, Titan sees neutral tone; Macquarie cuts targets on Pidilite, Britannia

A slew of brokerage reports released on May 9 offer fresh insights into institutional sentiment on key Indian stocks. Engineering major Larsen & Toubro (L&T) attracted widespread optimism, while views on Titan Company remained largely neutral with a slight tilt toward caution. Pidilite Industries and Britannia drew negative commentary from select analysts.

L&T share

Advertisement

Multiple brokerages reiterated their Buy ratings on L&T, reflecting continued confidence in the company’s execution track record and future growth visibility.

  • Axis Capital maintained its Buy call and raised the target price to ₹4,050 from ₹3,990.

  • Investec also maintained a Buy and revised the target upward to ₹4,115 from ₹4,030.

  • Jefferies followed suit, keeping its Buy rating with a new target of ₹3,965, up from ₹3,930.

  • Bernstein reaffirmed Buy with a target price of ₹3,922.

  • Haitong, however, cut its target from ₹4,050 to ₹3,800, still retaining a Buy stance.

  • Goldman Sachs maintained a Neutral rating, trimming the target to ₹3,260, signaling a more cautious outlook.

Titan share

Fund houses held neutral to cautious views on Titan, despite slight target price hikes.

  • Axis Capital maintained a Hold with a target of ₹3,700.

  • Morgan Stanley stayed Overweight, raising its target to ₹3,876.

  • Macquarie continued with an Outperform call and set a target at ₹4,000.

  • Jefferies and Haitong both settled at a Hold/Neutral rating with a target of ₹3,600.

  • Ambit maintained a Sell view with a target of ₹3,041.

  • Morgan Stanley also has a Underweight stance in another coverage, targeting a much lower ₹2,126.

Pidilite and Britannia share

  • Macquarie remained bearish on both Pidilite and Britannia, maintaining Underperform ratings.

    • For Pidilite, the target was cut to ₹2,600.

    • For Britannia, the revised target stood at ₹4,600.

These fund house recommendations come at a time when markets are actively reacting to Q4FY25 earnings and FY26 guidance commentary, offering key inputs for institutional and retail investors alike.


Disclaimer: This article is for informational purposes only. Business Upturn does not provide stock recommendations or investment advice. Please consult a certified financial advisor before making investment decisions.